As the healthcare landscape evolves to deliver on the promises of value-based care, integrated delivery networks (IDNs) have emerged as a dominant institutional care model in the US market. Meanwhile, biopharmaceutical manufacturers have struggled to understand the needs of IDNs and how to engage with them in a meaningful way. A comprehensive understanding of IDN needs and priorities is critical in developing relevant support programs and resources that will drive true partnerships. These organizations are not just powerful in terms of market share, but also in the ever-growing space of value-based contracting. It is critical to understand the diverse behaviors and needs of each unique IDN in order to use your team’s resources efficiently and effectively. By taking a number of customer engagement steps, manufacturers can build a strategy for effective IDN engagement.

Program Goals

  • At the completion of this program, participants should be able to:
  • Build your IDN expertise and core competencies around drivers and implications of IDNs.
  • Gain real customer insights around implications for biopharmaceutical companies – AMCP thought leaders and experts bring insight and meaning to their rapidly evolving business models.
  • Identify opportunities for manufacturers to distinguish themselves as valued partners.

Click here for additional information and registration details.


Related Content

Evidence Matters 2022

Evidence Matters 2022

Evidence Matters is a virtual one-day summit that brings the literature review community together from different industries to learn, engage, and solve ever-pressing evidence-based research challenges.